Cleared Traditional

K070011 - IBI INQUIRY CLEARICE INTRACARDIAC ECHOCARDIOGRAPHY ULTRASOUND IMAGING CATHETER

K070011 is an FDA 510(k) clearance for IBI INQUIRY CLEARICE INTRACARDIAC ECHOC..., manufactured by Irvine Biomedical,Inc.(Ibi). The device is a Class 2 Radiology device with product code DQO cleared through the Traditional 510(k) pathway after a 76-day FDA review.

K070011 · Irvine Biomedical,Inc.(Ibi) · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2007
Decision
76d
Days
Class 2
Risk

K070011 is an FDA 510(k) clearance for the IBI INQUIRY CLEARICE INTRACARDIAC ECHOCARDIOGRAPHY ULTRASOUND IMAGING CATHETER. Classified as Catheter, Intravascular, Diagnostic (product code DQO), Class II - Special Controls.

Submitted by Irvine Biomedical,Inc.(Ibi) (Irvine, US). The FDA issued a Cleared decision on March 20, 2007 after a review of 76 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 870.1200 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Irvine Biomedical,Inc.(Ibi) devices

FDA 510(k) Submission Details - K070011

510(k) Number K070011 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 03, 2007
Decision Date March 20, 2007
Days to Decision 76 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
31d faster than avg
Panel avg: 107d · This submission: 76d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQO Device Classification - Class 2, Special Controls

Product Code DQO Catheter, Intravascular, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1200
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - DQO Catheter, Intravascular, Diagnostic

All 378
Devices cleared under the same product code (DQO) and FDA review panel - the closest regulatory comparables to K070011.
MICRUS COURIER ENZO MICROCATHETER 0.0190
K072526 · Micrus Endovascular Corporation · Oct 2007
MICRUS COURIER ENZO MICROCATHETER 0.017
K070456 · Micrus Endovascular Corporation · May 2007
DYE MANAGEMENT SYSTEM
K063784 · Icu Medical, Inc. · Apr 2007
TWIN-PASS .023 DUAL ACCESS CATHETER, MODEL 5230
K062877 · Vascular Solutions, Inc. · Jan 2007
INNERCHANGE MICRO-INTRODUCER CATHETER, MODELS 7900 THROUGH 7905
K062627 · Vascular Solutions, Inc. · Jan 2007
MODIFICATION TO ATLANTIS SR PRO 2 AND SR PRO CORONARY IMAGING CATHETERS, MODEL 39014 AND 38942
K063312 · Boston Scientific Corp · Nov 2006